4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride → 4-Methyl-2-thiazol-2-yl-pyrimidine-5-carboxylic acid (3-ethyl-5-trifluoromethyl-pyrrolo[3,2-b]pyridin-1-yl)-amide
반응식
[CH3:1][C:2]1[C:7]([C:8]([OH:10])=O)=[CH:6][N:5]=[C:4]([C:11]2[S:12][CH:13]=[CH:14][N:15]=2)[N:3]=1.[CH2:16]([C:18]1[C:22]2=[N:23][C:24]([C:27]([F:30])([F:29])[F:28])=[CH:25][CH:26]=[C:21]2[N:20]([NH2:31])[CH:19]=1)[CH3:17].C[N+]1(C2N=C(OC)N=C(OC)N=2)CCOCC1.[Cl-]>CN(C=O)C.C([O-])([O-])=O.[Na+].[Na+]>[CH2:16]([C:18]1[C:22]2=[N:23][C:24]([C:27]([F:29])([F:30])[F:28])=[CH:25][CH:26]=[C:21]2[N:20]([NH:31][C:8]([C:7]2[C:2]([CH3:1])=[N:3][C:4]([C:11]3[S:12][CH:13]=[CH:14][N:15]=3)=[N:5][CH:6]=2)=[O:10])[CH:19]=1)[CH3:17]참가 물질
반응물 3
생성물 1
시약·촉매·용매 2
반응 조건
- 온도
- 50 °C
실험 절차
A solution of 4-methyl-2-thiazol-2-yl-pyrimidine-5-carboxylic acid (88 mg, 0.40 mmol) and 3-ethyl-5-trifluoromethyl-pyrrolo[3,2-b]pyridin-1-ylamine (89 mg, 0.40 mmol) in DMF (5 mL) is stirred at 50° C. for 1 h. The mixture is treated with DMTMM (113 mg, 0.41 mmol) and stirred at 50° C. overnight. The mixture is diluted with saturated aqueous Na2CO3 (5 mL) and stirred for 10 min. The precipitate is collected by filtration, washed with H2O (50 mL) and heptane (50 mL), and dried in vacuo to afford 4-methyl-2-thiazol-2-yl-pyrimidine-5-carboxylic acid (3-ethyl-5-trifluoromethyl-pyrrolo[3,2-b]pyridin-1-yl)-amide (75 mg, 40%). MS: 433 (M+H); 1H NMR (300 MHz, DMSO-d6): δ 12.19 (s, NH, 1H), 9.28 (s, 1H), 8.15 (m, 2H), 8.08 (d, 1H), 7.87 (s, 1H), 7.72 (d, 1H), 2.83 (q, 2H), 2.77 (s, 3H), 1.35 (t, 3H).
후처리
- stirringstirred for 10 min
- filtrationThe precipitate is collected by filtration
- washwashed with H2O (50 mL) and heptane (50 mL)
- customdried in vacuo
출처 및 근거
- ORD 기록
- ord-05d19c887b8f481192b643b8042e5a1b
- 출처 데이터셋
- uspto-grants-2012_09
- 특허 번호
- US08258130B2
반응 노트
불러오는 중…